REQUEST A DEMO
Total
USD $0.00
Search more companies

Marvel Drugs Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Marvel Drugs Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Marvel Drugs Pvt Ltd is an enterprise based in India. Its main office is in Mumbai. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on May 19, 1986. 11 - 50 (2025) employees currently work for Marvel Drugs Pvt Ltd. From the latest financial highlights, Marvel Drugs Pvt Ltd reported a net sales revenue drop of 29.63% in 2024. Its’ total assets recorded a growth of 16.3%. The net profit margin of Marvel Drugs Pvt Ltd decreased by 2.39% in 2024.

Legal Address
20, Nagin Mahal, 5Th Floor, 82, Veer Nariman Road, Churchgate
Mumbai; Maharashtra; Postal Code: 400020

Contact Details: Purchase the Marvel Drugs Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Marvel Drugs Pvt Ltd report to view the information.
Registered Capital:
Purchase the Marvel Drugs Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Marvel Drugs Pvt Ltd report to view the information.
Incorporation Date:
May 19, 1986
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
86.4%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Marvel Drugs Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-29.63%
Total Operating Revenue
-11.16%
Operating Profit
-35.92%
EBITDA
-33.88%
Net Profit/Loss for the Period
-35.47%
Total Assets
16.3%
Total Equity
9.75%
Operating Profit Margin
-3.54%
Net Profit Margin
-2.39%
Return on Equity (ROE)
-6.22%
Debt / Equity
8.6%
Quick Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?